MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.47 Million CAD | -50.9% |
| 2022 | 3 Million CAD | -30.01% |
| 2021 | 4.29 Million CAD | 7500.29% |
| 2020 | 56.46 Thousand CAD | 2127.46% |
| 2019 | 2535.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 220.57 Thousand CAD | -33.92% |
| 2024 Q1 | 333.77 Thousand CAD | -14.63% |
| 2024 Q3 | 281.77 Thousand CAD | 8.09% |
| 2023 Q4 | 390.99 Thousand CAD | 53.67% |
| 2023 Q2 | 420.13 Thousand CAD | -28.26% |
| 2023 Q1 | 585.64 Thousand CAD | -3.47% |
| 2023 FY | 1.81 Million CAD | -39.7% |
| 2023 Q3 | 254.44 Thousand CAD | -39.44% |
| 2022 Q3 | 562.74 Thousand CAD | -21.54% |
| 2022 Q2 | 717.23 Thousand CAD | -38.31% |
| 2022 Q1 | 1.16 Million CAD | -19.81% |
| 2022 FY | 3 Million CAD | -30.01% |
| 2022 Q4 | 606.72 Thousand CAD | 7.82% |
| 2021 Q3 | 899.27 Thousand CAD | 17.95% |
| 2021 FY | 4.29 Million CAD | 7500.29% |
| 2021 Q2 | 762.42 Thousand CAD | -35.39% |
| 2021 Q4 | 1.44 Million CAD | 61.23% |
| 2021 Q1 | 1.18 Million CAD | 0.0% |
| 2020 FY | 56.46 Thousand CAD | 2127.46% |
| 2019 FY | 2535.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | 71.593% |
| Asep Medical Holdings Inc | 7.74 Million CAD | 80.952% |
| BetterLife Pharma Inc. | 3.24 Million CAD | 54.485% |
| BioVaxys Technology Corp. | 2.4 Million CAD | 38.617% |
| ChitogenX Inc. | 2.83 Million CAD | 47.887% |
| Rapid Dose Therapeutics Corp. | 4.2 Million CAD | 64.957% |
| Defence Therapeutics Inc. | 12.65 Million CAD | 88.347% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | -161.341% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | 71.002% |
| Glow Lifetech Corp. | 25.71 Thousand CAD | -5635.123% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | -118.578% |
| Pharmala Biotech Holdings Inc. | 1.21 Million CAD | -21.177% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | -1945.843% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | -22.664% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | 51.552% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | -53.125% |
| Telescope Innovations Corp. | 6.35 Million CAD | 76.783% |